Topiramate Tablet, Film Coated
Product Images NDC 50090-7757

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-7757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure of topiramate, showing the molecular arrangement with sulfonamide, ether, and multiple methyl groups.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A cumulative rate graph showing time to first seizure in days for patients treated with topiramate at 50 mg/day and 400 mg/day doses. The x-axis represents time in days up to 500, and the y-axis represents cumulative rates for time to first seizure, ranging from 0 to 0.50. The graph includes sample sizes (N=234 for 50 mg/day, N=236 for 400 mg/day) and a p-value of 0.0002.*
FDA Label Image

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)

Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar chart comparing change from baseline to double-blind phase in average monthly migraine period rate (± SE) across two studies. It shows results for placebo and topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day, with lower migraine rates at higher topiramate doses. Statistical significance markers indicate p-values less than 0.010 and 0.001 for several topiramate groups.*
FDA Label Image

Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)

FDA Label Image

Label Image (Lbl500907757)

Label Image (Lbl500907757)
Topiramate USP 50 mg film-coated tablets label from A-S Medication Solutions. The label specifies each tablet contains 50 mg of topiramate, with storage instructions to keep at 68-77 degrees Fahrenheit and protect from moisture. The package contains 90 tablets. Product NDC is 50090-7757.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.